Literature DB >> 24027009

Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.

Mark Drost1, Hester Koppejan, Niels de Wind.   

Abstract

Lynch syndrome (LS) is a common cancer predisposition caused by an inactivating mutation in one of four DNA mismatch repair (MMR) genes. Frequently a variant of uncertain significance (VUS), rather than an obviously pathogenic mutation, is identified in one of these genes. The inability to define pathogenicity of such variants precludes targeted healthcare. Here, we have modified a cell-free assay to test VUS in the MMR gene PMS2 for functional activity. We have analyzed nearly all VUS in PMS2 found thus far and describe loss of MMR activity for five, suggesting the applicability of the assay for diagnosis of LS.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  DNA mismatch repair; Lynch syndrome; PMS2; VUS

Mesh:

Substances:

Year:  2013        PMID: 24027009      PMCID: PMC3858603          DOI: 10.1002/humu.22426

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

1.  PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance.

Authors:  Johanna M M van Oers; Sergio Roa; Uwe Werling; Yiyong Liu; Jochen Genschel; Harry Hou; Rani S Sellers; Paul Modrich; Matthew D Scharff; Winfried Edelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

2.  The E705K mutation in hPMS2 exerts recessive, not dominant, effects on mismatch repair.

Authors:  Suzanne M Deschênes; Guy Tomer; Megan Nguyen; Naz Erdeniz; Nicole C Juba; Natalia Sepúlveda; Jenna E Pisani; R Michael Liskay
Journal:  Cancer Lett       Date:  2006-10-09       Impact factor: 8.679

3.  A cell-free assay for the functional analysis of variants of the mismatch repair protein MLH1.

Authors:  Mark Drost; Jos e B M Zonneveld; Linda van Dijk; Hans Morreau; Carli M Tops; Hans F A Vasen; Juul T Wijnen; Niels de Wind
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

4.  Functional PMS2 hybrid alleles containing a pseudogene-specific missense variant trace back to a single ancient intrachromosomal recombination event.

Authors:  Christina Ganster; Annekatrin Wernstedt; Hildegard Kehrer-Sawatzki; Ludwine Messiaen; Konrad Schmidt; Nils Rahner; Karl Heinimann; Christa Fonatsch; Johannes Zschocke; Katharina Wimmer
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

5.  Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability.

Authors:  J B Basil; E M Swisher; T J Herzog; J S Rader; A Elbendary; D G Mutch; P J Goodfellow
Journal:  Gynecol Oncol       Date:  1999-09       Impact factor: 5.482

6.  Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.

Authors:  David E Goldgar; Douglas F Easton; Graham B Byrnes; Amanda B Spurdle; Edwin S Iversen; Marc S Greenblatt
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

7.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

Authors:  Leigha Senter; Mark Clendenning; Kaisa Sotamaa; Heather Hampel; Jane Green; John D Potter; Annika Lindblom; Kristina Lagerstedt; Stephen N Thibodeau; Noralane M Lindor; Joanne Young; Ingrid Winship; James G Dowty; Darren M White; John L Hopper; Laura Baglietto; Mark A Jenkins; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2008-05-02       Impact factor: 22.682

8.  Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.

Authors:  Mahdi Montazer Haghighi; Ramin Radpour; Katayoun Aghajani; Narges Zali; Mahsa Molaei; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2009-05-29       Impact factor: 2.571

9.  Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).

Authors:  Yvonne M C Hendriks; Shantie Jagmohan-Changur; Heleen M van der Klift; Hans Morreau; Marjo van Puijenbroek; Carli Tops; Theo van Os; Anja Wagner; Margreet G F M Ausems; Encarna Gomez; Martijn H Breuning; Annette H J T Bröcker-Vriends; Hans F A Vasen; Juul Th Wijnen
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

Review 10.  Mismatch repair deficient colorectal cancer in the era of personalized treatment.

Authors:  Madeleine Hewish; Christopher J Lord; Sarah A Martin; David Cunningham; Alan Ashworth
Journal:  Nat Rev Clin Oncol       Date:  2010-02-23       Impact factor: 66.675

View more
  10 in total

Review 1.  Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.

Authors:  Laura Valle; Eduardo Vilar; Sean V Tavtigian; Elena M Stoffel
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

2.  Elucidating the clinical significance of two PMS2 missense variants coexisting in a family fulfilling hereditary cancer criteria.

Authors:  Maribel González-Acosta; Jesús Del Valle; Matilde Navarro; Bryony A Thompson; Sílvia Iglesias; Xavier Sanjuan; María José Paúles; Natàlia Padilla; Anna Fernández; Raquel Cuesta; Àlex Teulé; Guido Plotz; Juan Cadiñanos; Xavier de la Cruz; Francesc Balaguer; Conxi Lázaro; Marta Pineda; Gabriel Capellá
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

Review 3.  The changing landscape of Lynch syndrome due to PMS2 mutations.

Authors:  J Blount; A Prakash
Journal:  Clin Genet       Date:  2018-03-15       Impact factor: 4.438

4.  Biochemical and structural characterization of two variants of uncertain significance in the PMS2 gene.

Authors:  Brandon M D'Arcy; Jessa Blount; Aishwarya Prakash
Journal:  Hum Mutat       Date:  2019-01-30       Impact factor: 4.878

5.  The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers.

Authors:  Manon Suerink; Heleen M van der Klift; Sanne W Ten Broeke; Olaf M Dekkers; Inge Bernstein; Gabriel Capellá Munar; Encarna Gomez Garcia; Nicoline Hoogerbrugge; Tom G W Letteboer; Fred H Menko; Annika Lindblom; Arjen Mensenkamp; Pal Moller; Theo A van Os; Nils Rahner; Bert J W Redeker; M J W Olderode-Berends; Maran Olderode; Liesbeth Spruijt; Yvonne J Vos; Anja Wagner; Hans Morreau; Frederik J Hes; Hans F A Vasen; Carli M Tops; Juul T Wijnen; Maartje Nielsen
Journal:  Genet Med       Date:  2015-06-25       Impact factor: 8.822

Review 6.  Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair.

Authors:  Marlo K Thompson; Robert W Sobol; Aishwarya Prakash
Journal:  Biology (Basel)       Date:  2021-06-14

7.  PMS2 variant results in loss of ATPase activity without compromising mismatch repair.

Authors:  Brandon M D'Arcy; Jennifer Arrington; Justin Weisman; Steven B McClellan; Zhengrong Yang; Champion Deivanayagam; Jessa Blount; Aishwarya Prakash
Journal:  Mol Genet Genomic Med       Date:  2022-02-21       Impact factor: 2.473

8.  Predictive functional assay-based classification of PMS2 variants in Lynch syndrome.

Authors:  Emily Rayner; Yvonne Tiersma; Cristina Fortuno; Sandrine van Hees-Stuivenberg; Mark Drost; Bryony Thompson; Amanda B Spurdle; Niels de Wind
Journal:  Hum Mutat       Date:  2022-04-28       Impact factor: 4.700

9.  A functional assay-based procedure to classify mismatch repair gene variants in Lynch syndrome.

Authors:  Mark Drost; Yvonne Tiersma; Bryony A Thompson; Jane H Frederiksen; Guido Keijzers; Dylan Glubb; Scott Kathe; Jan Osinga; Helga Westers; Lisa Pappas; Kenneth M Boucher; Siska Molenkamp; José B Zonneveld; Christi J van Asperen; David E Goldgar; Susan S Wallace; Rolf H Sijmons; Amanda B Spurdle; Lene J Rasmussen; Marc S Greenblatt; Niels de Wind; Sean V Tavtigian
Journal:  Genet Med       Date:  2018-12-03       Impact factor: 8.822

10.  Prioritizing variants of uncertain significance for reclassification using a rule-based algorithm in inherited retinal dystrophies.

Authors:  Ionut-Florin Iancu; Almudena Avila-Fernandez; Ana Arteche; Maria Jose Trujillo-Tiebas; Rosa Riveiro-Alvarez; Berta Almoguera; Inmaculada Martin-Merida; Marta Del Pozo-Valero; Irene Perea-Romero; Marta Corton; Pablo Minguez; Carmen Ayuso
Journal:  NPJ Genom Med       Date:  2021-02-23       Impact factor: 8.617

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.